When CMS requires this test before any reimbursement then this stock will be worth something. Until then, we be pissing in the wind. CMS gave CAMH a backhanded slap when it approved it for reimbursement but did not make it a requirement. They recognized it's importance, it's usefulness, it's accuracy while at the same time bending to the lobby of the big medical device MFGS. who make implantable defibrilators.

Low life Texas president and his lowlife sidekick he appointed to the FDA. We deserve what we got.